To accomplish this, healthy isolated CD56+ cells were incubated in complete media containing low-dose rIL-2 and supplemented with either healthy plasma +/− rTGF-β1 (used as a positive control) or baseline or POD1 plasma from CRC surgery patients for 24 h (Supplemental Table S2). Here, NCAM1 is linked to colorectal carcinoma.